Larvol Delta - A-Study-Comparing-BLM07D1-With-DS8201-in-Patients-With-HRPositive-HER2Low-Expressing-RecurrentMetastatic-Breast-Cancer

Imfinzi (durvalumab) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT02273375

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next